Key Metrics of ResMed
Revenue$4.2B▲ 18.0% YoYFY 2023
Operating income$1.1B▲ 13.2% YoY
Net profit$898M▲ 15.3% YoY
Shareholders' equity$4.5B
Market cap$35.6BRMD · $253.06
Competitors10identified
Open jobs2
About ResMed
Part of ResMed.
Sectors
Company details
- Website
- resmed.com
- Listed
- NYSE: RMD
Operational Areas of ResMed
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameResMed Inc.
TickerRMD
ExchangeNYSE
CountryUnited States
SEC CIK0000943819
Listed since—
IndustryMedical/Dental Instruments
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttp://www.resmed.com
US market & SEC filings
RMD · NYSE · SEC CIK 0000943819
Last price · 23 Oct 2026
$253.06
+2.79%
Market cap$35.6B
P/E41.6On FY 2023 diluted EPS
Volume1,728,830
SectorHealth CareMedical/Dental Instruments
Country · IPOUnited States
RMD share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeSan Diego
GSTIN—
Email—
Websitehttp://www.resmed.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of ResMed
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Part of ResMed
Business activities and related parties
medicine
Filings
No filings on record yet.